Squadron Capital Management LLC Top Holdings and 13F Report (2026) About Squadron Capital Management LLCInvestment ActivitySquadron Capital Management LLC has $322.25 million in total holdings as of June 30, 2026.Squadron Capital Management LLC owns shares of 38 different stocks, but just 16 companies or ETFs make up 80% of its holdings.Approximately 39.05% of the portfolio was purchased this quarter.About 32.53% of the portfolio was sold this quarter.This quarter, Squadron Capital Management LLC has purchased 33 new stocks and bought additional shares in 10 stocks.Squadron Capital Management LLC sold shares of 6 stocks and completely divested from 15 stocks this quarter.Largest Holdings Relmada Therapeutics $50,862,000C4 Therapeutics $35,492,000Cogent Biosciences $33,475,500Zentalis Pharmaceuticals $20,011,100Kodiak Sciences $19,480,000 Largest New Holdings this Quarter 09077V100 - BIOAGE LABS INC $9,926,550 Holding20451W101 - Compass Pathways $8,560,750 Holding29337E102 - Enliven Therapeutics $8,120,000 Holding76200L309 - Rezolute $6,777,732 Holding005329107 - Adagene $5,250,000 Holding Largest Purchases this Quarter C4 Therapeutics 5,350,000 shares (about $24.98M)BIOAGE LABS INC 405,000 shares (about $9.93M)Compass Pathways 605,000 shares (about $8.56M)Enliven Therapeutics 160,000 shares (about $8.12M)Inventiva 1,900,000 shares (about $7.18M) Largest Sales this Quarter Relmada Therapeutics 1,124,571 shares (about $7.78M)ADLAI NORTYE LTD 500,355 shares (about $5.75M)Edgewise Therapeutics 60,000 shares (about $2.44M)INHIBIKASE THERAPEUTICS INC 500,000 shares (about $1.02M)PASITHEA THERAPEUTICS CORP 1,100,000 shares (about $566.94K) Sector Allocation Over TimeMap of 500 Largest Holdings ofSquadron Capital Management LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorRLMDRelmada Therapeutics$50,862,000$7,782,031 â–¼-13.3%7,350,00015.8%HealthcareCCCCC4 Therapeutics$35,492,000$24,984,500 â–²237.8%7,600,00011.0%HealthcareCOGTCogent Biosciences$33,475,500$2,999,560 â–²9.8%865,00010.4%HealthcareZNTLZentalis Pharmaceuticals$20,011,100$460,750 â–²2.4%4,126,0006.2%HealthcareKODKodiak Sciences$19,480,000$4,675,200 â–²31.6%500,0006.0%HealthcareRLAYRelay Therapeutics$18,148,700$2,759,725 â–²17.9%970,0005.6%HealthcareEWTXEdgewise Therapeutics$11,782,700$2,437,800 â–¼-17.1%290,0003.7%HealthcareMAZE THERAPEUTICS INC$9,996,400$2,312,600 â–²30.1%335,0003.1%COMBIOAGE LABS INC$9,926,550$9,926,550 â–²New Holding405,0003.1%COMIVAInventiva$9,204,300$7,182,000 â–²355.1%2,435,0002.9%HealthcareADLAI NORTYE LTD$8,796,074$5,754,083 â–¼-39.5%764,8762.7%SPONSORED ADSCMPSCompass Pathways$8,560,750$8,560,750 â–²New Holding605,0002.7%HealthcareELVNEnliven Therapeutics$8,120,000$8,120,000 â–²New Holding160,0002.5%HealthcareRZLTRezolute$6,777,732$6,777,732 â–²New Holding1,303,4102.1%HealthcareARRIVENT BIOPHARMA INC$6,357,420$2,536,020 â–²66.4%183,0002.0%COMPALISADE BIO INC$6,270,0000.0%3,000,0001.9%COMINHIBIKASE THERAPEUTICS INC$6,090,000$1,015,000 â–¼-14.3%3,000,0001.9%COM NEWADAGAdagene$5,250,000$5,250,000 â–²New Holding1,250,0001.6%HealthcareFORTE BIOSCIENCES INC$4,781,250$4,781,250 â–²New Holding225,0001.5%COM NEWIFRXInflaRx$4,480,000$4,480,000 â–²New Holding2,000,0001.4%HealthcareASSEMBLY BIOSCIENCES INC$4,396,800$4,396,800 â–²New Holding160,0001.4%COM NEWPROMIS NEUROSCIENCES INC$4,276,6970.0%324,9771.3%COM SHSCONTINEUM THERAPEUTICS INC$4,261,400$4,261,400 â–²New Holding260,0001.3%CL ADEFINIUM THERAPEUTICS INC$3,998,400$3,998,400 â–²New Holding85,0001.2%COM SHSSOL-GEL TECHNOLOGIES LTD$3,855,280$1,556,940 â–²67.7%52,0001.2%SHS NEWSCYNEXIS INC$3,080,518$3,080,518 â–²New Holding756,8841.0%COMPRQRProQR Therapeutics$2,811,383$2,811,383 â–²New Holding1,511,4960.9%HealthcareIRONDisc Medicine$2,194,200$2,194,200 â–²New Holding30,0000.7%HealthcareLPCNLipocine$2,073,600$921,600 â–²80.0%810,0000.6%HealthcareRAREUltragenyx Pharmaceutical$1,836,450$1,836,450 â–²New Holding55,0000.6%HealthcareCUE BIOPHARMA INC$1,578,000$1,578,000 â–²New Holding50,0000.5%COMCALCCalciMedica$1,282,210$1,282,210 â–²New Holding1,244,8640.4%HealthcareQUINCE THERAPEUTICS INC$734,421$734,421 â–²New Holding40,3750.2%COMNVCTNuvectis Pharma$711,693$711,693 â–²New Holding38,7000.2%HealthcarePASITHEA THERAPEUTICS CORP$515,400$566,940 â–¼-52.4%1,000,0000.2%COM NEWINMED PHARMACEUTICALS INC$503,750$503,750 â–²New Holding325,0000.2%COM NEWNEUMORA THERAPEUTICS INC.$170,000$170,000 â–²New Holding100,0000.1%COMNEXTCURE INC$103,142$320,856 â–¼-75.7%64,4640.0%COM NEWKALVKalVista Pharmaceuticals$0$26,171,013 â–¼-100.0%00.0%HealthcareABIVAX SA$0$14,475,500 â–¼-100.0%00.0%SPONSORED ADSNEKTAR THERAPEUTICS$0$8,993,750 â–¼-100.0%00.0%COM NEWIDYAIDEAYA Biosciences$0$7,473,676 â–¼-100.0%00.0%HealthcareSCYXSCYNEXIS$0$6,976,412 â–¼-100.0%00.0%HealthcareEUPRAXIA PHARMACEUTICALS INC$0$4,923,200 â–¼-100.0%00.0%COMGHRSGH Research$0$4,569,500 â–¼-100.0%00.0%HealthcareKARYOPHARM THERAPEUTICS INC$0$4,177,500 â–¼-100.0%00.0%COM NEWALXOALX Oncology$0$2,927,300 â–¼-100.0%00.0%HealthcareCNTXContext Therapeutics$0$2,882,000 â–¼-100.0%00.0%HealthcareTRAWS PHARMA INC$0$936,437 â–¼-100.0%00.0%COM NEWTXMDTherapeuticsMD$0$849,250 â–¼-100.0%00.0%HealthcareSPRUCE BIOSCIENCES INC$0$797,270 â–¼-100.0%00.0%COM NEWHOWLWerewolf Therapeutics$0$469,199 â–¼-100.0%00.0%HealthcareNEUPHORIA THERAPEUTICS INC$0$312,283 â–¼-100.0%00.0%COMShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
